Peer Review History
| Original SubmissionFebruary 20, 2026 |
|---|
|
-->PONE-D-26-02760-->-->Impact of a patient safety checklist on health literacy outcomes – A sub-study of a stepped wedge cluster randomized controlled trial-->-->PLOS One Dear Dr. Austarheim, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by May 30 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:-->
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only the individual author can complete the verification step; PLOS staff cannot verify ORCID iDs on behalf of authors. We look forward to receiving your revised manuscript. Kind regards, Fatemeh Zarei, PhD Academic Editor PLOS One Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 3. Thank you for stating the following in the Competing Interests section: “We have read the journal's policy and the authors of this manuscript have the following competing interests: Arvid Steinar Haugen is member of the European Society of Anaesthesiologists’ and Intensive Care (ESAIC) Patient Safety and Quality Committee, representing the International Federation of Nurse Anaesthetists (IFNA). The other authors have declared that no competing interests exist.” Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests). If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. Please include your updated Competing Interests statement in your cover letter; we will change the online submission form on your behalf. 4. Thank you for stating the following financial disclosure: “The Norwegian Council of Nurses granted a doctoral scholarship to AKSA, through the Department of Anesthesia and Intensive Care, Haukeland University Hospital, Bergen, Norway, for this study. Kristin Harris (KH), Hilde Valen Wæhle (HVW), Anette Storesund (AS), Randi Julie Tangvik (RJT), and Arvid Steinar Haugen (ASH) are affiliated with the Stepped Wedge Cluster Randomized Controlled Trial of PASC, which is funded by the Norwegian Council of Research (ID:320475). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.” We note that one or more of the authors is affiliated with the funding organization, indicating the funder may have had some role in the design, data collection, analysis or preparation of your manuscript for publication; in other words, the funder played an indirect role through the participation of the co-authors. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please do the following: 1. Review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. These amendments should be made in the online form. 2. Confirm in your cover letter that you agree with the following statement, and we will change the online submission form on your behalf: “The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section. 5. In the online submission form you indicate that your data is not available for proprietary reasons and have provided a contact point for accessing this data. Please note that your current contact point is a co-author on this manuscript. According to our Data Policy, the contact point must not be an author on the manuscript and must be an institutional contact, ideally not an individual. Please revise your data statement to a non-author institutional point of contact, such as a data access or ethics committee, and send this to us via return email. Please also include contact information for the third party organization, and please include the full citation of where the data can be found. 6. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions -->Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. --> Reviewer #1: Yes Reviewer #2: Yes ********** -->2. Has the statistical analysis been performed appropriately and rigorously? --> Reviewer #1: Yes Reviewer #2: No ********** -->3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #1: Yes Reviewer #2: Yes ********** -->4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.--> Reviewer #1: Yes Reviewer #2: Yes ********** -->5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)--> Reviewer #1: As the statistical reviewer I will focus on methods and reporting Major 1) The study had power problems because many participants scored at the very top of the health literacy scales, leaving little room to detect improvement, and the observed statistical power across outcomes was very low, meaning the study was unlikely to detect real differences even if they existed. Although the authors mention ceiling effects and note this may limit the ability to detect changes, they do not explicitly acknowledge that the study was under-powered overall, nor do they directly link the non‑significant findings to inadequate power. A driver of this was the very large assumed effect size. 2) report uncertainty in Cronbach's alpha, e.g. bootstrap. 3) no information as to how missing data were handled. all data were not complete I presume, so why weren't multiple imputation approaches used? 4) The analyses treated clusters as fixed covariates in a simple GLM rather than as random effects, which means the stepped‑wedge structure and within‑cluster correlation were not properly modelled. This is a methodological limitation because stepped‑wedge cluster trials typically require mixed‑effects models with random cluster effects to produce valid inferences. Can the authors expand on their choice? 5) Bonferroni corrections further reduce power, dramatically. this was not considered in the power calculations. effectively it compounds the problem severely. 6) the very high non response rate, and the risk of bias with younger/healthier patients less likely to respond is another problem. Arguably, sensitivivity analyses with multiple imputations and making assumptions for non-responders would provide some more information. Minor 1) univariable (not univariate) regressions are mentioned but multivariable regressions are reported? Reviewer #2: Title Mentioning the tools in title is not common The title emphasizes the ("checklist") rather than the mechanism or outcome. In the context of a null result (which we see in the abstract), this title is particularly problematic. Its suggestion : Patient Activation and Preoperative Health Literacy: Findings from a Stepped-Wedge Randomized Trial OR Title: Change to remove "checklist" and adopt a more classic structure (e.g., "Effect of a Patient-Driven Preoperative Intervention on Health Literacy: A Stepped-Wedge Cluster Randomized Sub-Study"). Abstract This is a strong opening in terms of scientific method (stating the hypothesis upfront). However, as a standalone abstract for a paper with null results, it sets a tone of "failure" that needs to be mitigated in the conclusion. No revision needed here Typo: "delivered preoperatively (≤ eight weeks." -> Missing closing parenthesis: (≤ eight weeks) "In each cluster, 50 patients were randomly drawn from 100 eligible patients, a total of 350 in each group." This is a confusing description of sampling. If it's a sub-study of an RCT, were the 700 patients the entire trial cohort for this sub-study? Or were 700 drawn from a larger pool? The phrase "randomly drawn from 100 eligible" suggests a random selection process within clusters. Results: Condense the 9 statistical lines into a single, clear summary sentence. Conclusion "The use of a patient-driven safety checklist did not lead to measurable improvements across health literacy questionnaire domains, and the hypothesis was not supported. The questionnaire tool had signs of ceiling effects, hence the checklist’s influence on patients’ health literacy remains unclear." "The hypothesis was not supported." vs "The checklist's influence... remains unclear." You cannot have it both ways in a single abstract. Either the intervention failed (null result) OR the measurement tool failed (inconclusive result). Suggestion for Rewrite: "In this stepped-wedge cluster trial, a preoperative patient safety checklist did not improve health literacy scores compared to standard care. However, the high baseline scores (ceiling effect) and a 49% response rate limit definitive interpretation of the intervention's true effect. Further research should focus on patient populations with lower baseline health literacy or utilize more sensitive measurement tools." Introduction • Change "reveal" to "reveals" or "revealed". • Add a sentence defining the specific domain of health literacy targeted. • Verify and potentially update Reference [9] regarding recent interventions. • Provide one concrete example of a PASC checklist item. • Add a brief note acknowledging the measurement challenge in this specific cohort. method • Timeline Discrepancy: 2022 vs 2023 start date • Correct the date in Abstract or Methods to match source data. • Design Lack of detail on stepped wedge steps/duration Add 1-2 sentences clarifying the number and length of steps. Sampling • "Randomly drawn 50 from 100" - Justification missing Explain why random sub-sampling was used (resource/logistical constraint). • ITT Analysis Unclear handling of missing data for 355 non-responders Specify: Complete Case Analysis or Imputation method • Outcome Measure No mention of known ceiling effect in this population Add note about ceiling effect risk in Primary Outcome section. • Typos Multiple minor spelling/formatting errors Result The Non-Responder Analysis is Flawed in Logic "Non-responders were younger than responders (mean age 54.1 vs. 62.0 years; P = 0.025) and more likely to have ASA I classification (60.4% vs. 39.6%)." The text states "Non-responders were... more likely to have ASA I classification." But ASA I means healthy patient. The data says 60.4% of non-responders were ASA I vs 39.6% of responders. So Healthier, younger patients were LESS likely to respond. This is the opposite of typical survey bias. Usually, sicker patients are too tired to respond. Here, healthier patients (who likely have higher health literacy) ignored the survey. Impact on Results: If the healthiest/highest literacy patients dropped out of the intervention group, the intervention effect might be underestimated. The authors MUST discuss this in the Limitations section (currently they only mention younger/healthier responded less, but don't connect the dots to health literacy bias). This is a major omission. Discussion "These findings suggest that there is no clear association... raising two possible explanations: either PASC did not directly affect health literacy domains, or the HLQ instrument lacked the sensitivity..." This is the exact same sentence logic as the Abstract Conclusion. While consistency is good, the Discussion should expand on this, not repeat it verbatim. The first paragraph of a Discussion should summarize the main finding and then immediately pivot to interpretation. Redundancy .please rewrite The "Trend" Signal in Domain 2 is Ignored in the Discussion Discussion mentions ceiling effects and qualitative findings but never addresses the near-significant 0.90 Beta in Domain 2. [PASC is considered highly operational, context specific and oriented toward patient safety, and oriented toward patient safety ] “oriented toward patient safety” duplicated in one sentence delet one Conclusion The conclusion should synthesize the three key takeaways from the Discussion: 1. Primary Finding: No significant difference in HLQ scores. 2. Methodological Insight: Ceiling effects in this high-functioning Norwegian cohort likely masked any true effect; the HLQ may be inappropriate for this specific intervention evaluation. 3. Signal of Interest: The trend toward improved information management (Domain 2) aligns with qualitative feedback and warrants further investigation using more sensitive, context-specific tools. ********** -->6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.--> Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 1 |
|
Effect of a Patient-Driven Perioperative Intervention on Health Literacy: A Stepped-Wedge Cluster Randomized Sub-Study PONE-D-26-02760R1 Dear Dr. Ann Kristin Sandsbakk Austarheim We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Fatemeh Zarei, PhD Academic Editor PLOS One Additional Editor Comments (optional): ---- Reviewers' comments: Reviewer's Responses to Questions -->Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.--> Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** -->2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. --> Reviewer #1: Yes Reviewer #2: Yes ********** -->3. Has the statistical analysis been performed appropriately and rigorously? --> Reviewer #1: Yes Reviewer #2: Yes ********** -->4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #1: (No Response) Reviewer #2: Yes ********** -->5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.--> Reviewer #1: Yes Reviewer #2: (No Response) ********** -->6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)--> Reviewer #1: I am satisfied with the authors' responses and the resulting changes to the paper. I have nothing else to add. Reviewer #2: Thanks for efforts . It was satisfying. All commnets point by points were adressed clearly ********** -->7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.--> Reviewer #1: No Reviewer #2: Yes: Fatemeh Zarei ********** |
| Formally Accepted |
|
PONE-D-26-02760R1 PLOS One Dear Dr. Austarheim, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Fatemeh Zarei Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .